Addiction Medicine
News
Good news, bad news for buprenorphine in opioid use disorder
The findings “underscore the need to pursue actions that expand access to buprenorphine-based OUD treatment,” said Dr. Beth Han and associates.
News
FDA approves combo pill for severe, acute pain
Seglentis contains 56 mg of celecoxib and 44 mg of tramadol.
Opinion
Substance use or substance use disorder: A question of judgment
Should we discharge the intoxicated patient as soon as they are safe to walk out or make every effort possible to find long-term solutions?
News
FDA OKs new high-dose naloxone product for opioid overdose
“The higher intramuscular doses of naloxone in ZIMHI should result in more rapid and higher levels of naloxone in the systemic circulation.”
News
Substance abuse boosts COVID hospitalization, death risk, even after vaccination
Investigators found about twice as many individuals with an SUD had a breakthrough COVID-19 infection as their counterparts without an SUD.
News
Opioid prescribing mapped: Alabama highest, New York lowest
The Medicare Part D opioid prescribing rate dropped in all 50 states from 2014 to 2019, but disparities remain.
News
COVID-19 hospitalization 80% more likely for smokers
These results contrast with previous studies that have suggested a protective effect of smoking against COVID-19.
News
‘Alarming’ increase in fake pills laced with fentanyl, methamphetamine, DEA warns
More than 9.5 million fake pills have been seized so far this year – more than the last 2 years combined.
News
As opioid deaths climb, human trials begin for vaccine
The first vaccine to enter a trial targets oxycodone.
News
Opioid overdoses tied to lasting cognitive impairment
One study in the review found that about 39% of people seeking buprenorphine treatment suffered from neurocognitive impairment.